A California-based biotech company is turning heads Wednesday morning after it was announced that the U.S. Bankruptcy Court granted an interim approval of the company’s $75...

To read the full story on AllPennyStocks.com, click here.

Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Sorrento Therapeutics Charts.
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Sorrento Therapeutics Charts.